MAKO Surgical Corp. (MAKO) is a medical device company that markets its robotic arm solution and orthopedic implants for minimally invasive orthopedic knee procedures. MAKO offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific, early to mid-stage osteoarthritic knee disease. Its robotic arm systems, branded as its first generation Tactile Guidance System (TGS), and its second generation RIO Robotic Arm Interactive Orthopedic system (RIO), utilize tactile guided robotic arm technology and patient specific visualization to prepare the knee joint for the insertion and alignment of its resurfacing implants through a small incision in a minimally invasive, bone preserving and tissue sparing procedure. MAKO has an intellectual property portfolio of more than 250 licensed or owned patents and patent applications relating to the areas of computer assisted surgery, robotics, haptics and implants.